Bovie Medical Corporation to Release Second Quarter 2017 Financial Results on August 2, 2017
July 10 2017 - 4:05PM
Business Wire
Bovie Medical (BVX), a maker of medical devices and
supplies and the developer of J-Plasma®, a patented new surgical
product, today announced that financial results for the second
quarter of 2017 will be released after the market closes on
Wednesday, August 2.
Management will host a conference call at 4:30 p.m. Eastern Time
on August 2 to discuss the results of the quarter and host a
question and answer session. To listen to the call by phone,
interested parties may dial 844-507-6493 (or 647-253-8641 for
international callers) and provide access code 51614469.
Participants should ask for the Bovie Medical Corporation Call. A
live webcast of the call will be accessible via the Investor
Relations section of the Company’s website and
at: https://event.on24.com/wcc/r/1462925/FFFEFCC2DEDC4963062FDE9C9430032A.
A telephonic replay will be available approximately two hours
after the end of the call through August 16, 2017. The replay can
be accessed by dialing 800-585-8367 for U.S. callers or
416-621-4642 for International callers and using the replay access
code: 51614469. The webcast will be archived on the Investor
Relations section of the Company's website.
About Bovie Medical Corporation
Bovie Medical Corporation is a leading maker of medical devices
and supplies as well as the developer of J-Plasma®, a patented
plasma-based surgical product for cutting, coagulation and ablation
of soft tissue. J-Plasma® utilizes a helium ionization process to
produce a stable, focused beam of ionized gas that provides
surgeons with greater precision, minimal invasiveness and an
absence of conductive currents through the patient during surgery.
Bovie Medical Corporation is also a leader in the manufacture of a
range of electrosurgical products and technologies, marketed
through both private labels and the Company's own well-respected
brands (Bovie®, IDS™, ICON™ and DERM™) to distributors worldwide.
The Company also leverages its expertise through original equipment
manufacturing (OEM) agreements with other medical device
manufacturers. For further information about the Company's current
and new products, please refer to the Investor Relations section of
Bovie Medical Corporation at www.boviemed.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170710006223/en/
Investor Relations:Westwicke PartnersMike Piccinino,
CFAManaging Director443-213-0500investor.relations@boviemed.com
Bovie (AMEX:BVX)
Historical Stock Chart
From Aug 2024 to Sep 2024
Bovie (AMEX:BVX)
Historical Stock Chart
From Sep 2023 to Sep 2024